US Biotechnology Firm Raises Fresh Capital Via Debt Financing US Biotechnology Firm Raises Fresh Capital Via Debt Financing Reviewed by Erwin Castro on August 13, 2018 Rating: 5
About the Author: Erwin Castro is a freelance tech writer, digital marketer, and web developer. He has written for online publications including Seeking Alpha, IB Times, Blasting News, Sportskeeda, and University Herald.